Search research articles
Contact Us
Filters
Showing results (11-20 of 95) with videos related to
Page
of 10
Sort By:
JCO Precision Oncology
|
March 16, 2022
Reply to A. Rizzo et al
Jennifer Gile, Amina Jatoi, Wen Wee Ma, et al.
Cancers
|
January 25, 2018
Contemporary Management of Localized Resectable Pancreatic Cancer
Anuhya Kommalapati, Sri Harsha Tella, Gaurav Goyal, et al.
Journal of Oncology
|
February 22, 2020
Implications for Tumor Microenvironment and Epithelial Crosstalk in the Management of Gastrointestinal Cancers
Yang Ge, C Benedikt Westphalen, Wen Wee Ma, et al.
Journal of Oncology
|
December 31, 2019
Role of the Microenvironment in Gastrointestinal Tumors
Nathaniel Weygant, Yang Ge, C Benedikt Westphalen, et al.
Molecular Cancer Therapeutics
|
August 1, 2019
Tumor Priming by SMO Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma Model
Jun Wang, Darren K W Chan, Arindam Sen, et al.
Clinical Colorectal Cancer
|
April 20, 2017
Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation
Danish Shahab, Emmanuel Gabriel, Kristopher Attwood, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2021
Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation
Qingxiang Lin, Zhicheng Qian, William J Jusko, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 10, 2023
Patient-Specific Microfluidic Cancer Spheroid Cultures for Testing Cancer Therapies
Daheui Choi, Alan M Gonzalez-Suarez, Daniel D Billadeau, et al.
The Oncologist
|
June 9, 2020
Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors
Mojun Zhu, Mohamad Bassam Sonbol, Thorvardur Halfdanarson, et al.
Oncology
|
January 19, 2013
A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan
Ahmad A Fora, Jeanne A McMahon, Greg Wilding, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 95) with videos related to
Sort By:
Page
of 10
JCO Precision Oncology
|
March 16, 2022
Reply to A. Rizzo et al
Jennifer Gile, Amina Jatoi, Wen Wee Ma, et al.
Cancers
|
January 25, 2018
Contemporary Management of Localized Resectable Pancreatic Cancer
Anuhya Kommalapati, Sri Harsha Tella, Gaurav Goyal, et al.
Journal of Oncology
|
February 22, 2020
Implications for Tumor Microenvironment and Epithelial Crosstalk in the Management of Gastrointestinal Cancers
Yang Ge, C Benedikt Westphalen, Wen Wee Ma, et al.
Journal of Oncology
|
December 31, 2019
Role of the Microenvironment in Gastrointestinal Tumors
Nathaniel Weygant, Yang Ge, C Benedikt Westphalen, et al.
Molecular Cancer Therapeutics
|
August 1, 2019
Tumor Priming by SMO Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma Model
Jun Wang, Darren K W Chan, Arindam Sen, et al.
Clinical Colorectal Cancer
|
April 20, 2017
Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation
Danish Shahab, Emmanuel Gabriel, Kristopher Attwood, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2021
Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation
Qingxiang Lin, Zhicheng Qian, William J Jusko, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 10, 2023
Patient-Specific Microfluidic Cancer Spheroid Cultures for Testing Cancer Therapies
Daheui Choi, Alan M Gonzalez-Suarez, Daniel D Billadeau, et al.
The Oncologist
|
June 9, 2020
Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors
Mojun Zhu, Mohamad Bassam Sonbol, Thorvardur Halfdanarson, et al.
Oncology
|
January 19, 2013
A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan
Ahmad A Fora, Jeanne A McMahon, Greg Wilding, et al.
Page
of 10